Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check3 days agoChange DetectedThe footer revision tag was updated to v3.5.5, replacing v3.5.4. This indicates a minor backend/template update without impacting visible study details or actions.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new Revision: v3.5.4 was added to the page and the previous Revision: v3.5.3 was removed, indicating an update to the page's revision history.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now reflects an updated ClinicalTrials.gov frontend revision (v3.5.3) instead of the previous one (v3.5.2), indicating a site release rather than a change to the trial’s content.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated: added Revision v3.5.2 and removed Revision v3.5.0.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.